This study focuses on the development of an in vitro digestion model simulating oral, gastric and small intestinal fluids, applicable to the digestion of all three macronutrients, carbohydrates, proteins and lipids. To that aim, the effect of integrating intestinal mucosal enzymes in the small intestinal phase of the digestion reaction was investigated, together with that of other parameters including pepsin and pancreatin concentration, and pH of the small intestinal phase. Individual carbohydrate and protein ingredients for which digestive properties in vivo are generally understood (i.e. common corn starch, whey protein isolate) were used as reference substrates to validate the model and, at the end of development, the model was applied to evaluate the digestion of a reference lipid ingredient (i.e. olive oil) and of all three macronutrients present in a whole food system. Carbohydrate, protein and lipid hydrolysis was monitored, respectively, by quantitation of glucose, free amino groups and free fatty acids released at different times of digestion. The results demonstrate that including intestinal mucosal enzymes in the intestinal phase of digestion in vitro allows efficient digestion of starch and other carbohydrates into final product glucose and it also influences protein hydrolysis. Digestion profiles consistent with published in vitro and in vivo data support the validity of the developed method as an advanced tool for screening digestion of all three macronutrients whether presented alone or in a whole food system, all in a single digestion reaction.
Introduction
Development of new food ingredients and food systems is an essential aspect of innovation in the food industry and, as an integral part of the development process, a profound chemical and rheological characterization of the new food ingredient or system is required. In addition, understanding of the digestive properties also becomes critical to the development of those new ingredients and food. Further, there is an increasing interest in the design of food structures to manipulate rate of digestion, as an approach to impact satiety and/or control location of nutrient delivery along the gastrointestinal tract [1] . A number of research articles have now demonstrated that matrix, structure, ingredient interactions and processing of foods can have a critical impact on digestion [1] [2] [3] .
In vivo digestion screening tests using animal or human subjects is economically hindered, time consuming and, in the case of ingredients under development,
unsafe. An alternative to in vivo digestion are in vitro digestion models which, while not without limitations, are widely accepted tools in the fields of food/feed science and nutrition to screen digestion properties prior to in vivo studies [4] .
Digestion is a highly complex physiological process which includes multiple phases (mouth, stomach, small and large intestine), each of them characterized by specific solutions of unique composition (enzymes, organic and inorganic components), distinct pH and physicochemical/mechanical processes. That level of complexity is very difficult to completely reproduce in vitro and models are normally adapted to integrate the aspects of digestion deemed to be most relevant for a specific scientific question. Without doubt, dynamic models, capable of adjusting conditions throughout the digestion test [5] [6] [7] [8] , have the ability to mimic a larger set of parameters than static models. Still, static models have an economical and large throughput advantage.
Historically, a number of static in vitro digestion models varying within a wide range of conditions have been developed [9] [10] , often focused on a particular application and dedicated to studying one single type of macronutrient.
For example, starch digestibility in vitro is typically evaluated by the technique of Englyst [11] which simulates gastric and small intestinal digestion, the later including porcine pancreatic α-amylase and fungal amyloglucosidase as digestive enzymes. This technique evaluates starch digestibility by determining, through glucose analysis, three fractions: a rapidly digested (20 min), a slowly digested (20 -120 min) and a resistant to digestion (not digested within 120 min) fractions. The in vitro analysis of lipid digestion, on the other hand, is often performed using a pH stat method, including a small intestinal digestion with pancreatic enzymes and for which the amount of neutralizing alkali is widely accepted to be equivalent to the fatty acids produced [12] [13] . Also a pH stat method is commonly accepted to evaluate in vitro digestion of proteins [14] . Inherent to the dissimilarities among these traditional methods is the inability to simultaneously evaluate the digestion in vitro all three macronutrients: carbohydrates, proteins and lipids. Advancements in this respect are seen in studies by [15] reporting the development of an in vitro digestion model that can be used to evaluate the decomposition of both proteins and lipids in milk, and also by [16] proposing a standard protocol for in vitro digestion of macronutrients and demonstrating predicted digestibility of starch in mouth, of protein in stomach and of lipid in the small intestine. More recently, a static in vitro digestion model [17] proposes harmonized conditions of digestion based on most recent knowledge from human determinations. While these newer models more precisely simulate many of the physiological conditions, there is recognition of the lack of a final step of small intestinal digestion [15] 
Description of the Model
The in vitro model developed to digest ingredients and foods simulates the mouth, stomach, and small intestine fluids and was adapted from [21] . The digestive solution compositions they reported for a fed state were initially followed except that glucose, glucuronic acid, glucosamine hydrochloride and bovine serum albumin were not included in our model. In addition, Candida rugosa Li- pase (CrL) and RIP-enzyme extract were introduced into the gastric and duodenal solutions, respectively. Thus, the initial composition of the digestive solutions simulating each of the digestive compartments was as follows. Saliva cock- [22] . After 2 h incubation at 37˚C with constant head-over-heels rotation, 0.3 ml of pre-warmed 0.2 M sodium phosphate buffer pH 6.5 are added to raise the pH of the saliva-gastric solution, followed by addition of 3 ml of a mixture of pre-warmed duodenal (7 U trypsin from pancreatin, 300 U pancreatic lipase, 70 mIU RIP-enzyme extract) and bile solutions (ratio 2:1) thus initiating the small intestinal phase of digestion. Thimerosal (19 mM solution) was added to final concentration of 10 ml/L to prevent bacterial growth. Working pH for small intestinal digestion was 6.3 ± 0.2, representative pH of the unstirred water layer that bathes the brush border [18] . Mixtures were incubated at 37˚C under constant head-over-heels rotation. Samples (0.33 ml) were taken recurrently at different time points during gastric (0, 2 h) and small intestine (0.5, 1, 2, 3, 4 h) phases of digestion. Gastric samples were neutralized with 5 M NaOH. All samples were centrifuged at 13,000 rpm and 4˚C for 3 min and rapidly frozen at −20˚C. This recurring sampling method was standard for carbohydrate and protein testing but was modified to a so called "one tube per sample and per time" method when testing lipid ingredient, thus eliminating errors inherent when aliquoting from heterogeneous liquid/oil phase digestive solutions. Each substrate, digested in triplicate, and duplicate blanks containing all the solutions but no substrate were run under the same incubation and mixing conditions. Digestion of carbohydrates, proteins or lipids was monitored, respectively, by determining glucose, free amino groups or free fatty acids released into the digestive solutions, by the methods indicated below.
Preparation of Crude Intestinal Mucosal Enzyme Extract from Rat Intestinal Acetone Powder
Rat Intestinal acetone Powder (RIP) was used as a source of small intestinal disaccharidases (i.e. maltase-glucoamylase, sucrase-isomaltase) [23] [24] and amino peptidases [25] . RIP (10 g) was suspended in 200 ml of cold 0.1 M Phosphate buffer (pH 6.0) and stirred on a magnetic stirrer for 3 h at 4˚C, followed by centrifugation at 10,000 rpm for 10 min at 4˚C. The supernatant was further filtered on pre-folded filter paper #588 (Whatman Schleicher & Schuell) and dialyzed against 0.1 M Phosphate buffer (pH 6.0) for 24 h at 4˚C during which time buffer was replaced once. Dialyzed solution was lyophilized and stored frozen at −20˚C for up to 3 months. The activity of the crude intestinal mucosal enzyme extract was standardized based on the sucrase-isomaltase activity which was determined using isomaltulose (palatinose) as substrate. Briefly, 0.06 g of crude enzyme extract, 5.4 ml of 0.1 M Phosphate buffer (pH 6.0) and 0.6 ml of 29 µM isomaltulose substrate were incubated at 37˚C in a shaking water bath for 30 min. The amount of liberated glucose was determined using the glucose oxidase-peroxidase assay, as described below. One unit of activity is defined as the amount of enzyme that released 1 µmol of glucose per minute under the conditions described.
Determination of Glucose Content
The glucose content of the samples was determined by an enzymatic (GOPO)-colorimetric reaction using Stanbio glucose Liquicolor reagent (Stanbio Laboratories). Briefly, 10 µl of sample or glucose standard (0 -4 mg/mL) were mixed with 1 ml glucose reagent and incubated at room temperature for 30 min. Absorbance was read at 500 nm (Synergy HT, Biotek). Results were expressed as percentage of total starch equivalent conversion to glucose.
Determination of Free Amino Groups
Free amino groups content was determined by TNBS (2,4,6-trinitrobenzene sulfonic acid; Picrylsulfonic Acid) method after protein precipitation with trichloroacetic acid (TCA) [26] . Briefly, 55% TCA solution was added to digesta samples at 1/10 (v/v) ratio and incubated at 4˚C for at least one hour. Samples were centrifuged at 13,000 rpm and 4˚C for 5 min and aliquots of clean supernatants were diluted 1/10 with 2.5% borate buffer pH 9. 
Determination of Free Fatty Acids (FFA)
FFAs were analyzed by Gas Chromatography (GC, Agilent 6890 Plus) using 
Determination of Trypsin Activity
Trypsin activity of pancreatin was measured as indicated in [17] , with modifications. Briefly, three concentrations of pancreatin (0.5, 0.25, 0.1 mg/ml) were prepared in double distilled cold water and stirred for 10 min. For each assay, 2.6 ml of 46 mM sodium phosphate buffer containing 11.5 mM CaCl 2 (pH 8.1), 0.3 ml of a 10 mM TAME (p-Toluene-Sulfonyl-L-arginine methyl ester) solution in double distilled water were pipetted into quartz cuvettes, mixed by inversion and incubated at room temperature in a spectrophotometer for 5 min. Then, for each concentration tested, 0.1 ml of pancreatin solution was added and absorbance at 247 nm recorded every minute for at least 10 min. The slope (ΔA247) was determined from the initial linear portion of the curve. For blank assays, no enzyme was added and absorbance was also recorded every minute for at least 10 min and the slope was then determined. Calculation of enzyme activity was performed using the following formula:
where: ΔA247 is the slope (unit absorbance/minute) determined from the initial linear portion of the curve, 3 is volume of reaction mix (ml), 540 is the molar extinction coefficient of TAME at 247 nm, and X is the quantity (mg) of pancreatin in the final reaction mixture. Precision Plus Protein Western C standard (#161-0376) was also run in the gels.
Electrophoresis

SDS-PAGE was performed using a Mini-Protean
Proteins were stained with Coomassie Safe (Bio-Rad Laboratories) and destained in water. Gels were imaged with a Li-Cor Odyssey infrared imager.
Results
Impact of Intestinal Mucosal Enzyme Extract (RIP-Enzyme Extract) Concentration on Starch Digestion
Concentration of intestinal mucosal enzyme extracts was optimized primarily for starch digestion, macronutrient for which disaccharidases present in these extracts are required to achieve complete conversion to final product glucose.
Common native corn starch, a material for which digestibility properties are commonly described in the literature, was selected as initial test substrate. In vitro digestion was evaluated under the initial conditions described in Materials and Methods with varying amounts of RIP-enzyme extract, ranging from 0 -270 mIU of sucrase-isomaltase activity per reaction, added to the small intestinal solution. As shown in Figure 1 , starch hydrolysis, as measured by final product glucose release, was not observed in the gastric phase of digestion while, in the small intestinal phase, starch digestion directly increased with the amount of RIP-enzyme extract. Thus, after 4 h of small intestinal phase less than 20% of starch (14.2% ± 0.5%) was converted to glucose in the absence of RIP-enzyme extract and around 35% digestion (34.7% ± 1.8%) was observed in the presence of the lowest amount of RIP-enzyme extract tested (17 mIU). Extent of starch digestion was enhanced up to 53.7% ± 1.0% in the presence of 34 mIU RIP-enzyme extract and close to 80% glucose release (77.7% ± 2.1%) was measured at the end of the intestinal phase of digestion in the presence of 70 mIU RIP-enzyme extract. Higher than 90% glucose was released at the end of small intestinal phase when including 140 or 270 mIU RIP-enzyme extract.
Effect of Varying Gastric and Duodenal Conditions in the Presence of a Given Concentration of Intestinal Mucosal Enzyme Extract on Starch Digestion
While maximum starch digestibility was demonstrated for the two highest Figure 2 , in the presence of 70 mIU of RIP-enzyme extract, maintaining the original intestinal pH (pH 7.2 ± 0.2) and lowering the amount of pepsin and pancreatin did not have an impact on the glucose release from corn starch compared to higher (original) inclusion of those digestive enzymes. However, lowering the intestinal pH by about one unit (pH 6.3 ± 0.2), resulted in faster and more extended hydrolysis of corn starch, despite the lower inclusion of pancreatin. Under these conditions (70 mIU RIP-enzyme extract, 211 U pepsin, 7 U trypsin activity from pancreatin, per reaction, and intestinal pH 6.3 ± 0.2), hydrolysis was comparable to that previously observed with original concentration of pepsin and pancreatin and 3 and 4 times higher amounts of RIP enzyme extract (140 and 270 mIU, respectively) (shown in Figure 1 ), with about 95% total glucose released after 4 h of small intestinal digestion. From these results, 211 U pepsin in the gastric phase, 70 mIU of RIP-enzyme extract (corresponding to about 15 g/L duodenal solution), and 7 trypsin U from pancreatin, respectively, in the small intestinal phase, and pH 6.3 ± 0.2 in the final small intestinal mix, were selected as adequate conditions for digestion of corn starch and utilized for further experiments.
Evaluation of the Effect of RIP Enzyme Extract and Varying Gastric and Duodenal Conditions on the in Vitro Digestion of Proteins
Intestinal mucosa is not only a source of disaccharidases but also aminopeptidase enzymes. As such, the effect of the inclusion dose of RIP enzyme extract optimized for carbohydrate digestion (70 mIU) was also evaluated on protein digestion. Whey Protein Isolate (WPI) was utilized as reference material. Consistent with the different conditions tested for carbohydrate digestion, whey protein digestion was also evaluated under high (original at start of method development) and low, factor of 11 and 9, pepsin and pancreatin concentrations, respectively, and high (7.2 ± 0.2) and low (6.3 ± 0.2) pH in the small intestinal phase. As it can be observed in Figure 3 , at the conditions tested at the start of method development (i.e. lease was detected at the end of 2 h gastric digestion. This rapidly increased up to about 40% free amino groups within 30 min of small intestinal digestion, reaching 57.5% ± 1.6% at the end of 4 h small intestinal phase. Addition of RIP-enzyme extract did not appear to influence the in vitro digestion of whey protein isolate and similar digestion, 58.4% ± 1.2% of amino groups release after 4 h of small intestinal digestion, was observed in the presence and in the absence of RIP-enzyme extract. In contrast, when lower concentrations of pepsin (211 U) and pancreatin (7 Trypsin U) were present, respectively 11× and 9× reduction from original inclusion dose, addition of RIP-enzyme extract positively impacted whey protein digestion. Thus, about 15% higher amino groups release was measured after 4h small intestinal phase when RIP-enzyme extract was included in the digestion reaction (51.4% ± 0.5%) compared to reactions lacking RIP-enzyme extract (36.9% ± 0.7%). Under the lower digestive enzymes (pepsin and pancreatin) conditions, lowering the pH of the small intestinal phase from 7.2 ± 0.2 to about 6.3 ± 0.2 did not result in appreciable differences. While about 10% higher free amino group release was obtained at the early stages of the intestinal phase under the conditions tested at the start of method development (40.4% ± 0.6% vs 30.0% ± 1.1% after 30 min), the fact that the extent of digestion, 58.4% ± 1.2% free amino groups, was comparable to that observed with the modified conditions selected for carbohydrate digestion (70 mIU RIP, 211 U pepsin and 7 U trypsin activity (from pancreatin), per digestion reaction, and intestinal pH 6.3 ± 0.2) (54.5% ± 0.8%), supports the adequacy of adopting the later conditions for protein digestion as well. The digestion of whey protein was also monitored by SDS-PAGE as seen in 
Reproducibility of Digestion: RIP Enzyme Extracted from Different Batches
To evaluate the reproducibility of digestion under the final conditions of the model, namely for corn starch and whey protein isolate, macronutrients for which intestinal mucosal enzymes are relevant, ingredients were submitted to the digestibility protocol using 3 different batches of RIP enzyme extracts. The three independent experiments (n = 3 biological replicates of RIP enzyme extracts) where the ingredients were tested in triplicate (total n = 9 replicates), and at different times of digestion, is shown in Table 1 . % CV of corn starch and whey protein isolate was lower than 8% at different times of digestion (0.5, 1, 2, 3 and 4 h small intestinal phase).
Lipid Olive Oil Digestion
As indicated in the Materials and Methods section, one tube per time per sample approach was used to minimize recovery losses due to the heterogeneity of the digestive solutions when testing lipids as single ingredients.
In vitro digestion of reference substrate olive oil was evaluated under the conditions selected for starch digestion and also adopted for protein digestion (70 mIU RIP-enzyme extract, 211 U pepsin and 7 U trypsin activity (from pancreatin), per digestion reaction, and intestinal pH 6.3 ± 0.2). Under these conditions, and in the absence of an adequate commercial mammalian gastric lipase, Candida rugosa lipase (CrL) was included in the gastric phase and tested at 1200 U per digestion reaction. As shown in Figure 5 
In Vitro Digestion of a Whole Food System
A commercially available product, Ensure nutrition powder, was selected as an example of a complete and balanced food system from which digestibility of all 3 macronutrients could be evaluated in the developed in vitro model, all within the same digestion reaction. In order to obtain enough amount of sample to perform all the analytical tests required, the in vitro digestion was scaled up by a factor of 6. Thus, when 1 ml, 2 ml and 3 ml of saliva, gastric and small intestinal solutions, respectively, represent the volumes of a typical reaction for a single Digestion of all three macronutrients proceeded simultaneously and the curves of digestion are shown in Figure 6 . For the carbohydrate component of the food system, 3.4% ± 1.2% of free glucose was detected at time zero of digestion and this amount was still present after 2 h of gastric phase; 34.0% ± 1.7%
and 64.3% ± 2.2% glucose equivalent percent of the total carbohydrate was observed during the first 30 min and after 4 h of small intestinal digestion, respectively. Regarding the protein component, 1.2% ± 0.4% free amino groups were detected after 2 h of gastric digestion and 24.6% ± 1.1% after 30 min of small intestinal phase. At the end of digestion, 52.3% ± 2.2% free amino groups were measured. About 10% FFA (w/w) was detected after 2 h of gastric digestion and about 48.4% ± 0.5% FFA (w/w) were measured after 0.5 h small intestinal digestion, reaching after 4 h, 66.8% ± 1.2% FFA (w/w).
Discussion
In this study, conditions of digestion in vitro were evaluated for achieving Figure 6 . In vitro digestion of a whole food system Ensure Nutrition Powder (n = 3). % Digestion represents Glucose (% of starch), Free Amino Groups (% of total) and Free Fatty Acids% (w/w), for carbohydrate, protein and lipid components, respectively. [18] . Digestion of starches in humans initially relies on α-amylase (both salivary and pancreatic) which hydrolyzes internal α-1,4 linkages and releases maltose and α-limit dextrins. Those become substrate for the mucosal α-glucosidases, including maltase-glucoamylase and sucrase-isomaltase complexes, with ability to hydrolyze α-1,4, α-1,6, and α-1,3 linkages in di-and oligo-saccharides [18] [30] . Furthermore, work with recombinant human small intestinal maltase-glucoamylase [31] has shown that this disaccharidase also has capability to hydrolyze native starch granules.
These authors also evaluated the impact of fungal Amyloglucosidase (AMG), enzyme typically included in in vitro models for carbohydrate digestion such as the extensively utilized Englyst method [11] , on morphology of native starches of different botanical origins and compared it to that of human recombinant maltase-glucoamylase. Interestingly, remarkable differences on the morphology of starch granules were observed by scanning electron microscopy, demonstrating different susceptibilities of raw starches from different botanical sources to the two enzymes (human and fungal), thus strengthening the significance of including mammalian intestinal mucosal enzyme extracts versus fungal Amyloglucosidase when modeling digestion in vitro. Additional evidence amplifying the physiological relevance of including mammalian intestinal mucosal enzymes in in vitro digestion models, as it relates to proteins, comes from the fact that more than 20 major peptidases have already been identified in the small intestinal brush border membrane of humans and rats [32] .
The initial in vitro conditions of digestion utilized in this study were based on the model described by [21] , a model that has been extensively used as reference by others [15] [33] . From there, this study focused on evaluating and optimizing the amount of intestinal mucosal enzyme extract needed to be incorporated into digestion reactions that would result in approximate to physiological digestion, in addition to evaluating its impact upon modifying other conditions of digestion, namely pepsin and pancreatin concentrations, and pH of small intestinal solution.
Intestinal mucosal extracts include a complex mixture of enzymes which makes quantitation of all activities difficult. Carbohydrate digestion was prioritized for testing and thus, standardization of the extract was done on the basis of were also adequate for protein and lipid digestion. For comparison, when converting the enzymatic activities into Units/g food, inclusion levels of pepsin and trypsin activity from pancreatin in our system were estimated to be, respectively, 2 and 6 times lower than the ones recommended in the standardized static in vitro digestion model which does not include intestinal mucosal enzymes [17] .
Reference [20] observed 55% degree of hydrolysis of whey isolated protein after 1 h gastric plus 1 h duodenal digestion under conditions similar to the recently proposed harmonized model [17] . Interestingly, these authors also demonstrated about 16% further extension of whey protein isolate hydrolysis (71%), when the 1 h gastrointestinal digests were incubated with BBMs vesicles from pigs for additional 6 h. This value of milk protein digestibility in the presence of BBM vesicles is higher than that observed in our study (50% -55% free amino groups) and could be explained by several factors. First, in our study, free amino group analysis of digested samples was performed on supernatants from TCA precipitation and a number of free amino groups from larger molecular weight peptides are removed in the precipitated fraction, this likely resulting in underestimation of free amino groups released from digestion and, hence, digestibili- has shown similar protein profiles of hydrolysis of whey protein components:
rapid hydrolysis of α-lactoglobulin and higher resistance of β-lactoglobulin at the duodenum site, both being fully hydrolyzed at the jejunal site.
Reference [22] [42] . In addition, an assessment of the digestive properties of Rhizopus oryzae, gastric rabbit and recombinant human (rHGL) gastric lipases in vitro [43] showed differences in extent of digestion, fatty acids affinity and morphology changes of oil globules during digestion of infant formula among the three lipases and, based on expectations from previous in vivo data, rHGL was shown to be the best surrogate for in vitro models. Fungal lipase was included in the gastric phase of an in vitro digestion looking at the immunogenic proteins and peptides released from cooked pasta [3] . More recently, a study evaluating the impact of different experimental factors, reported addition of Aspergillus niger lipase to the gastric juice for in vitro digestion of fish lipid to obtain triglyceride hydrolysis levels close to that occuring in vivo [44] .
It has been reported that lipase activity in the stomach may account for up to 10% and 25% of TAGs in solid and liquid meals, respectively [45] [46], with 95%
overall efficiency of fat absorption in humans [47] . In our study, lipolysis of olive oil resulted in about 6% FFA (w/w) release after 2 h of gastric digestion and The suitability of the model to provide, in a single reaction, digestibility data on the three macronutrients present in a whole food system (Ensure nutrition powder) was also demonstrated in this study. According to the nutrition facts label, Ensure's carbohydrate fraction includes corn syrup, maltodextrin and sucrose. Digestion of both corn syrup and maltodextrin is expected to generate equivalent glucose content. However only about half of sucrose's weight will be converted into glucose as it is a disaccharide composed of glucose and fructose.
Based on the 60% carbohydrate content (of which 23% sugars), after deducting the theoretical fructose content of sucrose ingredient, maximum glucose (i.e.
100% digestion) that could be expected to be released from digestion would be Despite the added complexity in composition of final digestive solution in this model due to the integration of small intestinal enzyme extract, our results were consistent and reproducible, as shown by lower than 8% CV at different times of small intestinal digestion for both corn starch and whey protein isolate, obtained from 3 independent experiment including 3 different batches of small intestinal enzyme extract tested, for each substrate, in triplicate.
Future perspectives of the model include its application to the understanding of how food composition, food matrix, particle size, processing and other conditions, impact the digestibility of either one or all three macronutrients in a food, this knowledge being relevant for the development of innovative food ingredients and foods that target delivery of nutrients to specific points of the gastrointestinal tract as well as foods with optimal nutritional properties.
Conclusion
In conclusion, the present study reports the development of an in vitro digestion 
